The Fondation Leducq in Paris, France, dedicated to improving human health through international efforts to combat cardiovascular disease, awarded a $6 million grant award to a new global research network of cardiovascular scientists which includes three researchers from the Cardiovascular Research Center at Icahn School of Medicine at Mount Sinai.
This new large grant was awarded as part of the Fondation Leducq's Transatlantic Networks of Excellence in Cardiovascular Research Program. Network researchers will aim to identify cellular and molecular targets to help advance cardiac regeneration therapeutics. Their research proposal was one of only four research projects selected this year for funding by the foundation from among one hundred applications. Research is planned to launch in January 2014.
The new global network brings together physician-scientists with leading expertise in developmental biology, cardiac stem cell biology, biomarkers, gene therapy, metabolism, immunology, pharmacogenomics, and clinical cardiology.
The new research network includes Mount Sinai's Roger Hajjar, MD, Director of the Cardiovascular Research Center at Mount Sinai, Jean-Sebastien Hulot, MD, PhD, Director of Pharmacogenomics and Personalized Therapeutics at the Cardiovascular Research Center at Mount Sinai, and Jason Kovacic, MD, PhD, Assistant Professor of Medicine in Cardiology at Mount Sinai. Other network members include: Toren Finkel, MD, PhD, of the National Institutes of Health, the North American Coordinator; David Sassoon, PhD, of the Universite de Pierre et Marie Curie-Sorbonne Universites in Paris, France, the European Coordinator; Thomas Braun, MD, PhD, of Max Planck Institute for Heart and Lung Research, Bad Nauheim, Germany; Richard Harvey, PhD, of Victor Chang Cardiac Research Institute, Sydney, Australia; Nadia Rosenthal, PhD, of the National Heart and Lung Institute, Imperial College in London, UK; and Mark Sussman, PhD, of San Di
|Contact: Lauren Woods|
The Mount Sinai Hospital / Mount Sinai School of Medicine